Trying to Get It Right: Adjuvant Therapy in RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Mehrazin R, Tsao C-K, Sfakianos J, Galsky MD. Systemic adjuvant therapy for renal cell carcinoma: Any hope for future clinical trials? Urol Oncol. 2016;34(5):221-224.
- Haas NB, Manola J, Uzzo RG. Initial results from ASSURE (E2805): adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial. J Clin Oncol. 2015;33([abstract 403]).
Disclosure statements are available on the authors' profiles: